After finishing at $3.65 in the prior trading day, Omega Therapeutics Inc (NASDAQ: OMGA) closed at $3.20, down -12.33%. In other words, the price has decreased by -$0.4500 from its previous closing price. On the day, 506781 shares were traded.
Ratios:
Our goal is to gain a better understanding of OMGA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.35 and its Current Ratio is at 3.35. In the meantime, Its Debt-to-Equity ratio is 2.21 whereas as Long-Term Debt/Eq ratio is at 1.95.
On December 08, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.
On September 23, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $12.Chardan Capital Markets initiated its Buy rating on September 23, 2022, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’23 when Young Richard A sold 5,000 shares for $8.00 per share. The transaction valued at 40,000 led to the insider holds 739,118 shares of the business.
Young Richard A sold 5,000 shares of OMGA for $40,000 on May 01 ’23. The Director now owns 744,118 shares after completing the transaction at $8.00 per share. On Apr 06 ’23, another insider, Young Richard A, who serves as the Director of the company, sold 5,000 shares for $8.00 each. As a result, the insider received 40,000 and left with 749,118 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OMGA now has a Market Capitalization of 176.50M and an Enterprise Value of 231.49M. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.92 while its Price-to-Book (P/B) ratio in mrq is 3.04. Its current Enterprise Value per Revenue stands at 74.82 whereas that against EBITDA is -2.48.
Stock Price History:
The Beta on a monthly basis for OMGA is 1.83, which has changed by -46.76% over the last 52 weeks, in comparison to a change of 28.14% over the same period for the S&P500. Over the past 52 weeks, OMGA has reached a high of $10.09, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is 3.7849, while the 200-Day Moving Average is calculated to be 3.3403.
Shares Statistics:
The stock has traded on average 2.19M shares per day over the past 3-months and 249.03k shares per day over the last 10 days, according to various share statistics. A total of 55.14M shares are outstanding, with a floating share count of 20.42M. Insiders hold about 62.98% of the company’s shares, while institutions hold 31.82% stake in the company. Shares short for OMGA as of Mar 15, 2024 were 3.88M with a Short Ratio of 1.77, compared to 3.31M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.04% and a Short% of Float of 19.93%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.21 and a low estimate of -$0.49, while EPS last year was -$0.5. The consensus estimate for the next quarter is -$0.39, with high estimates of -$0.22 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$0.89 and -$2.18 for the fiscal current year, implying an average EPS of -$1.54. EPS for the following year is -$1.22, with 3 analysts recommending between -$0.78 and -$1.79.
